🔎 Trials Near Me

Akèy › Kansè fwa (Kasinòm epatoselilè) › Distrik Columbia › Washington

Etid klinik pou Kansè fwa (Kasinòm epatoselilè) nan Washington, DC

10 etid pou Kansè fwa (Kasinòm epatoselilè) ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

The Vanguard Study: Testing a New Way to Screen for Cancer

Ap rekriteVolontè an sante akeyi
  • Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
Laj 45 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT06995898

A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Ap rekriteFaz 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Sep 22, 2026 · NCT06066138

Evaluating Novel Therapies in ctDNA Positive GI Cancers

Ap rekriteFaz 3
  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
  • Medstar Washington Hospital Center, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05482516

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05919264

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Ap rekrite
  • Washington DC VA Medical Center, Washington, DC, Washington D.C.
Laj 18 a 75 · Tout sèks · Mizajou Jun 17, 2026 · NCT05486572

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Ap rekriteFaz 2
  • USA11-0, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT06953089

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Ap rekriteFaz 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou May 19, 2026 · NCT06503146

GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies

Ap rekriteFaz 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Apr 7, 2026 · NCT05003895

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Silver Spring · 7 mi lwen
  • Massive Bio SYNERGY-AI site, Bethesda · 7 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kansè fwa (Kasinòm epatoselilè) nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.